Acquired aplastic anemia is usually fatal. During recent years autoimmune disturbances have been implicated in bone marrow depression. This has led to a novel therapeutic approach based on immune suppression to enable bone marrow recovery. We report 4 adult patients who were treated with antithymocyte globulin.